Patents Assigned to RxANTE, INC.
-
Patent number: 11887027Abstract: The present technology calculates a value of future adherence (VFA) score which is a patient-level, predicted, expected cost of conversion from non-adherence to adherence over a specified time-frame. The score consists of three general components: (1) probability of being non-adherent, (2) cost reduction associated with being adherent, and (3) probability of converting from non-adherent to adherent. These values can be combined to create an overall VFA score. A user interface is then provided which shows at least a list of patients and information related to the VFA score.Type: GrantFiled: January 30, 2023Date of Patent: January 30, 2024Assignee: RXANTE, INC.Inventors: Daniel Smith, Joshua Benner, Aaron McKethan, Loren Lidsky
-
Patent number: 11842365Abstract: The technology described herein relates to using predictions about patients' future health care utilization and/or outcomes (e.g., patients' expected future adherence to medication regimens) and the expected economic benefits of targeted improvements in the same utilization and/or outcomes (e.g., reduced likelihood of hospitalization attributable to more consistent medication use) to implement more effective and efficient health care improvement programs. The technology described here computes which subset of patients should be included in a value-based health care provider payment scheme and what the specific bonus payment amounts should be such that expected benefits from better patient outcomes, once realized, are greater than the expected costs of the payment scheme itself.Type: GrantFiled: May 13, 2022Date of Patent: December 12, 2023Assignee: RXANTE, INC.Inventors: Joshua S. Benner, Aaron McKethan, Kimball Lewis, Daniel Smith, Morgan Beschle, Spencer Cherry, Loren Lidsky
-
Patent number: 11586997Abstract: The present technology calculates a value of future adherence (VFA) score which is a patient-level, predicted, expected cost of conversion from non-adherence to adherence over a specified time-frame. The score consists of three general components: (1) probability of being non-adherent, (2) cost reduction associated with being adherent, and (3) probability of converting from non-adherent to adherent. These values can be combined to create an overall VFA score. A user interface is then provided which shows at least a list of patients and information related to the VFA score.Type: GrantFiled: July 1, 2020Date of Patent: February 21, 2023Assignee: RXANTE, INC.Inventors: Daniel Smith, Joshua Benner, Aaron McKethan, Loren Lidsky
-
Patent number: 11334902Abstract: The technology described herein relates to using predictions about patients' future health care utilization and/or outcomes (e.g., patients' expected future adherence to medication regimens) and the expected economic benefits of targeted improvements in the same utilization and/or outcomes (e.g., reduced likelihood of hospitalization attributable to more consistent medication use) to implement more effective and efficient health care improvement programs. The technology described here computes which subset of patients should be included in a value-based health care provider payment scheme and what the specific bonus payment amounts should be such that expected benefits from better patient outcomes, once realized, are greater than the expected costs of the payment scheme itself.Type: GrantFiled: October 18, 2018Date of Patent: May 17, 2022Assignee: RXANTE, INC.Inventors: Joshua S. Benner, Aaron McKethan, Kimball Lewis, Daniel Smith, Morgan Beschle, Spencer Cherry, Loren Lidsky
-
Patent number: 11244029Abstract: The disclosed methods and systems are generally directed to the combined application of predictive analytics with clinical decision analysis to provide optimal recommendations for the implementation of various health care management programs including, for example, prescription medication adherence interventions, and providing recommendations for medication adherence interventions for individual patients, based on predictions of patient adherence and predicted or expected responses to available interventions. Such interventions may be instituted in advance of a potential negative outcome, e.g., non-adherence, to prevent or reduce the occurrence of a negative outcome and realize greater return on investment.Type: GrantFiled: December 28, 2012Date of Patent: February 8, 2022Assignee: RXANTE, INC.Inventor: Joshua S. Benner
-
Patent number: 10706372Abstract: The present technology calculates a value of future adherence (VFA) score which is a patient-level, predicted, expected cost of conversion from non-adherence to adherence over a specified time-frame. The score consists of three general components: (1) probability of being non-adherent, (2) cost reduction associated with being adherent, and (3) probability of converting from non-adherent to adherent. These values can be combined to create an overall VFA score. A user interface is then provided which shows at least a list of patients and information related to the VFA score.Type: GrantFiled: May 20, 2019Date of Patent: July 7, 2020Assignee: RXANTE, INC.Inventors: Daniel Smith, Joshua Benner, Aaron McKethan, Loren Lidsky
-
Patent number: 10318897Abstract: The present technology calculates a value of future adherence (VFA) score which is a patient-level, predicted, expected cost of conversion from non-adherence to adherence over a specified time-frame. The score consists of three general components: (1) probability of being non-adherent, (2) cost reduction associated with being adherent, and (3) probability of converting from non-adherent to adherent. These values can be combined to create an overall VFA score. A user interface is then provided which shows at least a list of patients and information related to the VFA score.Type: GrantFiled: October 21, 2014Date of Patent: June 11, 2019Assignee: RXANTE, INC.Inventors: Daniel Smith, Joshua Benner, Aaron McKethan, Loren Lidsky
-
Patent number: 10108975Abstract: The technology described herein relates to using predictions about patients' future health care utilization and/or outcomes (e.g., patients' expected future adherence to medication regimens) and the expected economic benefits of targeted improvements in the same utilization and/or outcomes (e.g., reduced likelihood of hospitalization attributable to more consistent medication use) to implement more effective and efficient health care improvement programs. The technology described here computes which subset of patients should be included in a value-based health care provider payment scheme and what the specific bonus payment amounts should be such that expected benefits from better patient outcomes, once realized, are greater than the expected costs of the payment scheme itself.Type: GrantFiled: June 30, 2014Date of Patent: October 23, 2018Assignee: RxANTE, INC.Inventors: Joshua S. Benner, Aaron McKethan, Kimball Lewis, Daniel Smith, Morgan Beschle, Spencer Cherry, Loren Lidsky